Single Cell Therapeutics

Single Cell Therapeutics

Single-cell solutions can be used, based on the SARS-CoV-2 infection, to investigate the potential tropism of SARS-CoV-2, characterize phenotypic diversity before, during, and after SARS-CoV-2 infection, analyze new immune cell subpopulations in health and disease, and investigate potential cell surface markers and stage-specific pathogen antigens. These variations all contribute significantly to the search for new antiviral medications and the creation of viable immunomodulatory treatment approaches. Single-cell ATAC, single-cell gene expression, single-cell immunological profiling, and single-cell spatial gene expression are just a few of the single-cell solutions we offer to help find therapeutic targets.